financial estimates
MGI Tech Reports Preliminary 2022 Results
The Chinese next-generation sequencing instrumentation firm expects its net profit attributable to shareholders to be at least RMB 1.94 billion ($284.2 million).
Oxford Nanopore Technologies Expects 2022 Revenue to Rise 49 Percent
The company expects 2022 revenue to be approximately £199.0 million, including around £147.0 million in life science research tools revenue.
Pacific Biosciences Provides Updates on Platforms, Contracts at JP Morgan Conference
The firm won a population genomics contract in Dubai, launched a trusted partner network, and signed a bioinformatics collaboration deal.
Castle Biosciences Estimates 2022 Revenues in Line With Prior Projections
The company said it expects full-year revenues of at least $132 million to $137 million, with test volumes up significantly across the majority of its menu.
Exact Sciences Projects 28 Percent Bump in Total Q4 Oncology Revenue
The company expects to report consistent growth in both cancer screening and precision oncology testing for the quarter and the full fiscal year.